These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6152996)

  • 1. The effects of extremes of age on drug action.
    Wilson K; Hanson J
    Methods Find Exp Clin Pharmacol; 1980 Dec; 2(6):303-12. PubMed ID: 6152996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of maturation on drug disposition in pediatric patients.
    Stewart CF; Hampton EM
    Clin Pharm; 1987 Jul; 6(7):548-64. PubMed ID: 3319364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
    Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
    Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in pharmacokinetics: predictability and assessment methods.
    Perucca E
    Int Rev Neurobiol; 2007; 81():183-99. PubMed ID: 17433924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics in older adults: a review.
    Bowie MW; Slattum PW
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):263-303. PubMed ID: 17996666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy in the aged].
    Huber W; Turnheim K
    Wien Klin Wochenschr; 1987 Mar; 99(6):173-80. PubMed ID: 3590798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug disposition during the perinatal period.
    Heimann G
    Int J Biol Res Pregnancy; 1981; 2(1):1-14. PubMed ID: 7341492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
    Nong A; McCarver DG; Hines RN; Krishnan K
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of isepamicin.
    Barr WH; Colucci R; Radwanski E; Zampaglione N; Cutler D; Lin CC; Elliott M; Affrime MB
    J Chemother; 1995 Jun; 7 Suppl 2():53-61. PubMed ID: 8622111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling.
    Bouzom F; Walther B
    Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy in the elderly.
    Turnheim K
    Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants.
    Ginsberg G; Hattis D; Sonawane B
    Toxicol Appl Pharmacol; 2004 Jul; 198(2):164-83. PubMed ID: 15236952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic monitoring of the elderly in critical care.
    Planchock NY; Slay LE
    Crit Care Nurs Clin North Am; 1996 Mar; 8(1):79-89. PubMed ID: 8695038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal differential aging processes and ofloxacin pharmacokinetics in the elderly].
    Corvaisier S; Bleyzac N; De Montclos M; Druguet M; Albrand G; Carret G; Maire P
    Therapie; 1999; 54(2):223-31. PubMed ID: 10394258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.